ZYUS Life Sciences (TSXV:ZYUS) Scaled Net Operating Assets : 0.66 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

ZYUS Life Sciences's operating assets for the quarter that ended in Mar. 2024 was C$35.67 Mil. ZYUS Life Sciences's operating liabilities for the quarter that ended in Mar. 2024 was C$8.29 Mil. ZYUS Life Sciences's Total Assets for the quarter that ended in Dec. 2023 was C$41.63 Mil. Therefore, ZYUS Life Sciences's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.66.

ZYUS Life Sciences Scaled Net Operating Assets Historical Data

The historical data trend for ZYUS Life Sciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences Scaled Net Operating Assets Chart

ZYUS Life Sciences Annual Data

Trend

Dec21

Dec22

Dec23

Scaled Net Operating Assets

0.42

ZYUS Life Sciences Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial					0.57	0.69	0.60	0.38	0.66

Competitive Comparison of ZYUS Life Sciences's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, ZYUS Life Sciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ZYUS Life Sciences's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ZYUS Life Sciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where ZYUS Life Sciences's Scaled Net Operating Assets falls into.

ZYUS Life Sciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

ZYUS Life Sciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(35.775	-	8.707)	/	64.712
=	0.42

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	41.627	-	5.852
=	35.775

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	18.513	-	3.253	-	6.553
=	8.707

ZYUS Life Sciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(35.668	-	8.288)	/	41.627
=	0.66

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	38.221	-	2.553
=	35.668

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	18.15	-	3.297	-	6.565
=	8.288

ZYUS Life Sciences Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of ZYUS Life Sciences's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

ZYUS Life Sciences (TSXV:ZYUS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

ZLSCF:USA

Address

407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8

Website

https://www.zyus.com

ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.

Executives

John Michael Hyshka

Senior Officer

ZYUS Life Sciences (TSXV:ZYUS) Headlines

No Headlines